Yoda Pharmaceuticals Inc. (TPEX:7829)
Taiwan · Delayed Price · Currency is TWD 41.50
+0.25 (0.61%)
At close: Jun 18, 2026
Yoda Pharmaceuticals Market Cap
Yoda Pharmaceuticals has a market cap or net worth of 3.29 billion as of June 18, 2026.
Market Cap
3.29B
Enterprise Value
2.97B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
41.50
Market Cap Chart
Since June 3, 2025, Yoda Pharmaceuticals's market cap has increased from 2.92B to 3.29B, an increase of 12.93%. That is a compound annual growth rate of 12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 3.29B | -29.18% |
| Dec 31, 2025 | 4.65B | 59.46% |
| Jun 3, 2025 | 2.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LIWANLI Innovation | 5.46B |
| SCI Pharmtech | 5.28B |
| Orient EuroPharma | 3.92B |
| Easywell Biomedicals | 3.83B |
| Tien Liang BioTech | 3.07B |
| Maywufa Company | 2.90B |
| Merdury Biopharmaceutical | 2.65B |
| Allied Biotech | 2.59B |